INTRODUCTION
Congenital hypoplastic anemia (Diamond-Blackfan syndrome, "erythrogenesis imperfecta," congenital pure red cell anemia) is an outstanding example of an isolated, chronic underproduction of one cell line. The condition is due to an error in hematologic development in which erythropoiesis is either profoundly diminished or completely absent. In the early months of life, a Received for publication 14 February 1975 and in revised form 30 October 1975. progressive anemia develops, characterized by absent reticulocytosis and reduced marrow erythroid elements. About one-half of these children experience a complete remission when treated with corticosteroids (1) . Since the serum erythropoietin (EPO)1 levels are consistently elevated (2) , various etiological possibilities must be considered. The disorder could be due to absent or reduced erythroid progenitors or stem cells, decreased responsiveness of stem cells to EPO, the presence of an abnormal EPO, an "unfavorable" marrow microenvironment, or the presence of an inhibitor of erythropoiesis as seen in adults with acquired pure red cell aplasia (3) (4) (5) (6) (7) (8) .
To investigate the pathogenesis of this syndrome, we have used a tissue culture method in which marrow cells grown in a plasma clot respond to exogenous EPO with the appearance of discrete nucleated erythroid colonies (9) . Each colony represents the differentiation of an erythroid progenitor or precursor (9, 10) and thus allows the study of earlier events in erythropoiesis than was heretofore possible in vitro.
METHODS
Patients. Four patients with congenital hypoplastic anemia were studied. Their clinical and hematological data are summarized in Table I . All fit the classic clinical description for this disorder. The only hematological abnormality was anemia due to failure of red cell production. The other cell lines were normal. Patients 1 and 4 had responded initially to daily prednisone with an increase in hemoglobin to normal; at the time of study, the dosage was reduced and they were anemic again. Patient 3 had been treated with prednisone for 2i yr during which the hemoglobin was normal. Because of growth failure, it was stopped before study and the hemoglobin fell, necessitating monthly transfusions. Patient 2, a sibling of patient 3, had not received prednisone and required monthly transfusions.
Controls. Marrows from 30 other children were cultured for erythroid colonies. These children had marrow aspirates performed during investigations for malignancy, storage disease, and idiopathic thrombocytopenic purpura. Although not considered "normal" in the strict sense, and not a homogeneous population, all had normal hemoglobin con1Abbreviation used in this paper: EPO, erythropoietin. (9) with some modification. 3 ml of bone marrow was aspirated in a dry syringe and transferred to 5 ml of supplemented Eagle's minimum essential medium (Grand Island Biological Co., Grand Island, N. Y.), 2% fetal calf serum, and 10 U/ml of preservative-free heparin. After centrifugation, the supernate was discarded, and the cells were resuspended in the same solution without heparin and recentrifuged. Buffy coat was removed and suspended in Eagle's medium in a final concentration of 1 X 10' nucleated cells/ml. The following were combined: 0.7 ml bovine serum albumin (Miles Laboratories Inc., Elkhart, Ind.); 0.7 ml beef embryo extract (Grand Island Biological Co.); 0.7 ml Lasparagine (Sigma Chemical Co., St. Louis, Mo.); 1.4 ml NCTC-109 (Microbiological Associates, Bethesda, Md.); and 2.1 ml fetal calf serum. From this mixture, 0.8 ml was placed into five separate tubes. To each tube was added 0.1 ml of the cell suspension containing 1 X 10' nucleated cells and 0.1 ml EPO in varying concentrations so that the final culture concentrations were: 0.5, 1.0, 2.0, and 2.5 U/ml. EPO was obtained from anemic sheep plasma (Connaught Laboratories, Toronto, Canada) and had a potency of 2.8-4.7 U/mg dry weight (step III). It was reconstituted with NCTC-109 and frozen until used. NCTC-109 without EPO was added to the last tube. Finally, 0.1 ml of bovine plasma was added to each tube, mixed with the contents, and, before clotting, plated rapidly into the wells of plastic titration plates (Linbro Chemical Co., New Haven, Conn.). Cultures were incubated at 37'C in air with 5%o CO2 in high humidity.
After 7-8 days of incubation, the plasma clots were removed from the wells and placed on microscope slides.
Filter paper was placed over the clots and, by rolling with a pipette, the clots were flattened. The clots were fixed in 5%o glutaraldehyde in 0.01 M phosphate buffer for 10 min, washed in distilled water for 10 min, and dried in an air stream. The slides were stained in 1% 3,3-dimethoxybenzidine (Eastman Kodak Co., Rochester, N. Y.) in methanol for 3M min, then in 3%o hydrogen peroxide in 70% ethanol for 1 min. After rinsing in distilled water, they were counterstained with Harris' hematoxylin for 2 min, airdried, and mounted with cover slips. The clots were scanned at lOOX magnification and the total number of colonies per clot was counted. A colony was defined as a clump of eight or more nucleated cells showing a positive brown-orange benzidine reaction. All determinations were done in quadruplicate and the results averaged. The counts were expressed as number of colonies per 1 X 10' nucleated cells plated. To determine the reproducibility of the colony assay, the results of the quadruplicate values in the control marrows at each EPO dosage were subjected to an analysis of variance (11) . To compare colony size the numbers of cells in 100 colonies from each of the patients and four controls were counted.
Marrows from patients 1 and 2 were also cultured in methylcellulose for granulocyte colonies by a modification of the original method (12) . Cultures contained conditioned medium (CSA) prepared from peripheral blood leukocytes of a normal adult. Results were expressed as number of colonies per 1 X 10' nucleated cells plated.
Mixing experiments. To detect the presence of a serum inhibitor to either EPO or erythroid progenitors, a control marrow was cultured in the presence of sera from patients 2, 3, and 4, which substituted for fetal calf serum. Serum from patients 3 and 4 was cultured with autologous marrow. To demonstrate the culture system is capable of detecting an inhibitor, autologous and control marrow was cultured in the presence of serum from an adult with acquired pure red cell aplasia who has a documented inhibitor to erythropoiesis (13) . Normal human AB serum was used as control. To test sera from other anemic patients, control marrow was cultured with sera from two children with constitutional Fanconi's aplastic anemia treated by transfusion The number of erythroid colonies per 1 X 10' nucleated cells cultured in the four children with congenital hypoplastic anemia is shown in Table III . Marrow from patient 1 had no colony growth in cultures containing up to 1.0 U/ml EPO. At 2.5 U/ml there were normal numbers. The cultures at 2.0 U/ml were contaminated. Marrow from patient 2 had colony growth at all EPO concentrations but the numbers were consistently lower than normal. Patient 3 had colony growth in all EPO-containing cultures just at or below the lower normal limit. Patient 4 had normal colony growth in all cultures except for that with 2.5 U/ml, where the number was below normal. Colonies were of similar size to those of controls.
Results of studies to detect serum inhibitors are shown in Figs. 1 and 2 . There was no decrease in colonies at the serum concentrations tested. In the two studies using autologous marrow some increase in colony growth resulted; in patient 3, colony numbers increased to normal levels in the autologous serum cultures. 
DISCUSSION
The etiology and pathogenesis of congenital hypoplastic anemia has not been adequately explained. Prenatal factors seem to be operative in most patients since anemia is often present at birth, there is an increased incidence of congenital malformations, and sibling involvement suggests a genetic influence (14) . There is little evidence to suggest that maternal-fetal isoimmune problems, maternal drug ingestion, fetal chromosomal abnormalities, or intrauterine infections play a role in the etiology. The theory that a disturbance of tryptophan metabolism was responsible for the anemia (15) lost favor when it was demonstrated that abnormal excretion of tryptophan metabolites occurs in a variety of anemias and is nonspecific (16) . Since EPO levels are consistently elevated in children with congenital hypoplastic anemia (2), it is logical to study the marrow erythroid line to see if the mechanism of end-organ failure can be clarified. The earliest morphologically identifiable erythroid element is the pronormoblast; however, there are precursors present in marrow that cannot be identified by traditional morphologic methods. A current and widely held concept of erythropoiesis is that erythroid differentiation begins with a single pluripotent stem cell, moves through a unipotent EPO-responsive or "committed" stem cell, and ends as a cohort of hemoglobin-producing erythrocytes (17) . Studies of early events in erythropoiesis have been facilitated by the introduction of a tissue culture method for growth of erythroid colonies (9, 10) . There is cogent evidence that these colonies are in the erythroid line. They grow in response to added EPO, the hormone that controls production of erythrocytes (18) Unfortunately serial studies of these patients were not possible.
Mixing experiments failed to reveal any serum inhibitor of EPO or erythroid precursors at the serum concentrations used, with either autologous marrow or control marrow. It is impossible to use final concentrations of serum greater than 30% without impairing the tissue culture system; therefore, the presence of weak inhibitors could be missed. The method seems to be capable of detecting a serum inhibitor, as serum from the adult with acquired red cell aplasia strikingly reduced colony growth from autologous and control marrow. This contrasts with the results in the congenital variety and suggests that the mechanism of the two disorders may be different. Normal human AB serum did not have this effect, indicating culture conditions remained adequate.
No inhibition was seen with serum from the two children with Fanconi's anemia and in one there was increased colony growth. Inhibition at a cellular level cannot be ruled out but is unlikely as the patients' marrows did form colonies in vitro.
